Zürich Area, Switzerland
Director Global Peptides & Sterile Injectables Platform at CordenPharma Group
Pharmaceuticals
Education
Université Pierre et Marie Curie (Paris VI) 1989 — 1995
PhD, Organic Chemistry
Université Pierre et Marie Curie (Paris VI) 1990 — 1991
Master's degree, Biochemistry
Université Paris Nord- Paris 13 1987 — 1989
DEUG (Diplome d'Etudes Universitaires Générales, Sciences
Experience
Corden Pharma GmbH November 2013 - Present
GKL Biotec AG September 2010 - Present
Peptisyntha (Member of Solvay group until Oct 2013 then acquired by Corden Pharma) December 2009 - October 2013
Senn Chemicals AG April 2007 - December 2009
Genzyme Pharmaceuticals March 2004 - March 2007
Senn Chemicals AG September 1997 - February 2004
Isochem (SNPE Pharma) March 1995 - August 1997
Skills
Organic Chemistry, Pharmaceutical Industry, GLP, Peptides, Technology Transfer, International Sales, Project Management, Pharmaceuticals, Commercialization, HPLC, Organic Synthesis, CRO, Drug Delivery, R&D, Clinical Development, Life Sciences, Biopharmaceuticals, Quality System, Drug Discovery, Drug Development, Chemistry, Sop, Cross-functional Team..., Team Building, Lifesciences, Process Development, GMP, Strategic Planning, Validation, Negotiation, Biotechnology, Product Development, Outsourcing, Manufacturing, Product Management, Formulation, Due Diligence, Oncology, Purification, Strategy, Pharmaceutics, Regulatory Affairs, Contract Negotiation, Chromatography, Process Simulation, FDA, cGMP, Analytical Chemistry, Leadership, Biochemistry